Financials

  • Market Capitalization 181.78 M
  • Employee 146
  • Founded 2002
  • CEO John Nicols
  • Website www.codexis.com
  • Headquarter Delaware, United States
  • FIGI BBG000RN0GZ5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.26
Price to sales ratio
2.02

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3676
ADAG
Adagene Inc - ADS, each representing 1.25
3.90 USD+1.30%-5.11%+3.45%+79.72%184.80 M USD
3682
SPRB
Spruce Biosciences, Inc. - Common Stock
63.30 USD+2.96%+20.62%+54.88%+475.45%181.93 M USD
3694
CRBU
Caribou Biosciences, Inc. - Common Stock
1.66 USD+0.61%+1.22%+9.93%-13.99%177.96 M USD
3702
QSI
Quantum-Si Incorporated - Class A Common Stock
0.80 USD+1.27%+1.27%+5.26%-29.82%175.11 M USD

Frequently asked questions about Codexis, Inc.

What is the Codexis, Inc. stock price today?

The current price of Codexis, Inc. (CDXS) is 1.66. Over the past 24 hours, the stock has changed by +0.61%. Follow the CDXS chart for real-time price dynamics.

What is the stock ticker of Codexis, Inc.?

Codexis, Inc. trades under the ticker CDXS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Codexis, Inc. stock going up?

CDXS has changed by +3.75% over the last week, +11.41% over the last month, and -38.75% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Codexis, Inc.?

Codexis, Inc. currently has a market capitalization of 181.78 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Codexis, Inc. earnings last quarter?

Last quarter, Codexis, Inc. reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Codexis, Inc. revenue for the last quarter?

Codexis, Inc. reported quarterly revenue of 14.91 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Codexis, Inc. net income for the last quarter?

Codexis, Inc. reported net income of -12.01 M for the last quarter. The previous quarter showed -8.7 M, which means net income changed by -37.93%.

How many employees does Codexis, Inc. have?

As of the latest available data, Codexis, Inc. has 146 employees. Workforce size can provide additional context about the company's scale and operations.

What is Codexis, Inc. EBITDA?

Codexis, Inc. EBITDA is -10.02 M, and its EBITDA margin is -67.17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Codexis, Inc. stock?

You can buy Codexis, Inc. (CDXS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Codexis, Inc. stock?

Investing in Codexis, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CDXS chart and related analysis on metatrader.com as part of your research.

Codexis, Inc. - Common Stock

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

News